HEALTH News, Jul 15, 2011 (2)

Panel backs stricter blood cancer drug label Thu,14 Jul 2011 03:12 PM PDT Reuters - SILVER SPRING, Maryland (Reuters) - A U.S. advisory panel backed an experimental drug from Seattle Genetics Inc for treating two rare types of blood cancer, but recommended stricter labeling than the company sought. Full Story   U.S. medical devices spending steady: report Thu,14 Jul 2011 02:44 PM PDT Reuters - WASHINGTON (Reuters) - Medical devices accounted for about 6 percent of the total U.S. health spending in 2009, barely changed from 10 years earlier and slightly higher than two decades ago, according to an industry report. Full Story Vitamin A may not prevent asthma: study Thu,14 Jul 2011 02:43 PM PDT Reuters - NEW YORK (Reuters Health) - Despite the important role of vitamin A in lung development, researchers have found that giving the nutrient to pregnant women or preschoolers in Nepal doesn't protect kids against asthma. Full Story Black men survive longer in prison than out: study Thu,14 Jul 2011 02:42 PM PDT Reuters - NEW YORK (Reuters Health) - Black men are half as likely to die at any given time if they're in prison than if they aren't, suggests a new study of North Carolina inmates.Full Story FDA panel backs Seattle Genetics drug for lymphoma Thu,14 Jul 2011 12:57 PM PDT Reuters - SILVER SPRING, Maryland (Reuters) - An experimental drug from Seattle Genetics Inc garnered unanimous backing from U.S. advisers for a second type of blood cancer. Full Story EU customs seize $1.4 billion of fake goods in 2010 Thu,14 Jul 2011 11:53 AM PDT Reuters - BRUSSELS (Reuters) - Customs officials seized fake goods worth more than one billion euros ($1.4 billion) at European borders last year as they paid more attention to shipments ordered online, the European Commission said in a report on Thursday. Full Story Vitamin C from food tied to lower cataract risk Thu,14 Jul 2011 11:41 AM PDT Reuters - NEW YORK (Reuters Health) - Older adults who get very little vitamin C in their diets may have an increased risk of developing cataracts, a study in India finds. Full Story Flu vaccine production to double by 2015, WHO says Thu,14 Jul 2011 11:18 AM PDT Reuters - GENEVA (Reuters) - Global production of seasonal flu vaccine is expected to double to 1.7 billion doses by 2015, with 11 new manufacturers coming onstream in developing countries, the World Health Organization (WHO) said on Thursday. Full Story Does adrenaline help cardiac arrest victims survive? Thu,14 Jul 2011 11:14 AM PDT Reuters - NEW YORK (Reuters Health) - People who've suffered cardiac arrest usually get a shot of adrenaline to help their heart back on track, but in a controversial study fromAustralia the hormone did little to increase patients' survival. Full Story Are narrow blood vessels to blame in MS? Thu,14 Jul 2011 09:12 AM PDT Reuters - NEW YORK (Reuters Health) - Despite a few well-publicized studies and many hopeful patients waiting for treatment, there is no good evidence that multiple sclerosis, or MS, is caused by a blood vessel condition, a fresh look at the medical literature finds. Full Story Parents underestimate kids' asthma symptoms Thu,14 Jul 2011 08:48 AM PDT Reuters - NEW YORK (Reuters Health) - Parents of kids with asthma don't always realize when their children's treatment is inadequate, a new drugmaker-funded survey suggests. Full Story Landmark lupus drug Benlysta approved in Europe Thu,14 Jul 2011 08:37 AM PDT Reuters - LONDON (Reuters) - Benlysta, the first new treatment for lupus in half a century, was approved for use in Europe, the drug's discoverer Human Genome Sciences and partner GlaxoSmithKline said on Thursday. Full Story Do tea, coffee drinkers have lower "superbug" risk? Thu,14 Jul 2011 08:24 AM PDT Reuters - NEW YORK (Reuters Health) - People who regularly drink tea or coffee may be less likely to carry the antibiotic-resistant "superbug" MRSA in their nostrils, a new study suggests. Full Story NICE seen at heart of new UK drug pricing system Thu,14 Jul 2011 07:59 AM PDT Reuters - LONDON (Reuters) - Britain's cost-effectiveness health watchdog NICE expects to play a central role in a value-based pricing system for new medicines due to take effect from 2014, according to its chief executive. Full Story FDA hires former Dartmouth dean to new post as part of rejig Wed,13 Jul 2011 08:45 PM PDT Reuters - BANGALORE (Reuters) - The U.S. Food and Drug Administration has named former Dartmouth Medical School Dean Stephen Spielberg to the newly created position of deputy commissioner for medical products and tobacco, according to an internal letter sent to FDA employees that was obtained by Reuters. Full Story

email: info@als-alexander.org or interalex2@gmail.com